1998
DOI: 10.1016/s0002-9270(98)00059-8
|View full text |Cite
|
Sign up to set email alerts
|

Metal Stents for the Palliation of Inoperable Upper Gastrointestinal Stenoses

Abstract: We sought to determine the efficacy of metal stents in the palliation of malignant upper gastrointestinal stenoses. Six patients with inoperable malignant obstruction of the upper gastrointestinal tract, intractable nausea and vomiting, and an inability to maintain an oral intake were studied. A metal stent was inserted under endoscopic control and deployed in the stenosis. Stents were successfully deployed in all patients, and there were no immediate complications. All patients were able to eat after the proc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
17
0
1

Year Published

1999
1999
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(19 citation statements)
references
References 0 publications
1
17
0
1
Order By: Relevance
“…Tumor ingrowth occurred in 14 (26.4%) patients at a mean of 78.4 d in our study. Overall recurrent stenosis rates of 8%-46% at an interval of 2-21 wk (mean, 7.5 wk) have been reported in other studies [14,15,[19][20][21][22][23][24] . It is difficult to compare our results with results of other studies because other reports included patients with a variety of cancers.…”
Section: Discussionsupporting
confidence: 65%
“…Tumor ingrowth occurred in 14 (26.4%) patients at a mean of 78.4 d in our study. Overall recurrent stenosis rates of 8%-46% at an interval of 2-21 wk (mean, 7.5 wk) have been reported in other studies [14,15,[19][20][21][22][23][24] . It is difficult to compare our results with results of other studies because other reports included patients with a variety of cancers.…”
Section: Discussionsupporting
confidence: 65%
“…Remarkably, 13% (80/606) patients in this review were treated with a covered esophageal stent placed in the distal stomach/proximal jejunum. A clear drawback of uncovered stents in the duodenum is the occurrence of hyperplastic tissue or tumor growth through the mesh of the stent [15][16][17]. In the present study, we only used uncovered stents, whereas a second uncovered stent for tissue or tumor ingrowth was performed for six occluded stents in five patients.…”
Section: Discussionmentioning
confidence: 96%
“…However, there is limited recurrence of obstructive symptoms resulting from tumour ingrowth, stent migration and tumour overgrowth. Restenosis by tumour ingrowth is the most common problem of uncovered stents [7,9,18]. Nassif et al [19] reported a 19.0% tumour ingrowth rate of …”
Section: Discussionmentioning
confidence: 99%